Rebalix
iShares · sheet of 5 September 2026
iShares · sheet of 5 September 2026ETF sheet · official issuer and register data
iShares Global High Yield Corp Bond UCITS ETF
HYLA · IE00BYWZ0440 · USD · domicile Ireland
Bonds · High yield USD · Broad (all maturities) · GlobalSFDR art. 6
Index tracked: iBoxx Global Developed Markets Liquid High Yield Capped (USD) Index (USD)
- TER
- 0.50%+ trans. 0.06%
- Fund size
- 573 m EUR
- Tracking difference
- −0.35%3-year avg
- 🇮🇹 tax rate
- 25.95%white list 0.35%
- Replication
- Physical (optimised)
- Income
- Accumulating
- Duration
- 2.95 yrsshort (≤3 years)
Launch 19 Oct 2017 · costs from the KID as of 2 Sept 2026 · 1,995 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the iBoxx Global Developed Markets Liquid High Yield Capped Index (the Index). The Fund is passively managed and aims to invest so far as possible and practicable in the fixed income (FI) securities (such as bonds) that make up the Index and comply with its credit rating requirements. If the credit ratings of the FI securities are upgraded to investment grade or downgraded to default grade or credit…
Performance since series start (in euro) — base 100
19 Oct 2017 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.1% |
| 3 years | +19.8% |
| 5 years | +18.8% |
| 10 years | series too young |
| Since series start | +40.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.15% | 5.06% | 6.36% |
| Max drawdown | −3.92% | −4.89% | −22.26% |
| Sharpe | 0.38 | 1.02 | 0.11 |
| Sortino | 0.57 | 1.56 | 0.16 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · HYLA · IE00BYWZ04401
RebalixHYLA · IE00BYWZ0440 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +14.63% | +14.84% | −0.21% |
| 2024 | +2.95% | +3.30% | −0.35% |
| 2023 | +13.43% | +13.92% | −0.48% |
| 2022 | −12.50% | −12.19% | −0.32% |
| 2021 | +0.46% | +0.79% | −0.33% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 1.9%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 1,995 securities · top-10 weight = 2.9%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
2B7G · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 5 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BYWZ0440
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BYWZ0440
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · HYLA · IE00BYWZ04402